Gilead Sciences reports $1.46B in investment holdings

Gilead Therapeutics A1 Unlimited Co is listed as the report's one other included manager.

Available on EDGAR 11/06/2026 - 06:02 AM EST Accepted by SEC EDGAR 11/05/2026 - 05:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Gilead Sciences (GILD), acting as an institutional investment manager, reported a Form 13F holdings report with 5 information-table entries and a reported value total of $1,463,841,605, rounded to the nearest dollar. The report lists Gilead Therapeutics A1 Unlimited Co as 1 other included manager.

Filing Explained

The cover page marks Gilead Sciences’ filing as a holdings report, with the selected category stating that all holdings of the reporting manager are reported here; this clarifies that the schedule is presented as the manager’s complete holdings report.

Key Figures

13F Information Table Value Total: $1,463,841,605 Information-table entries: 5 entries Other included managers: 1 manager

3 metrics

13F Information Table Value Total $1,463,841,605 Rounded to the nearest dollar

Information-table entries 5 entries Form 13F summary

Other included managers 1 manager Gilead Therapeutics A1 Unlimited Co

Key Terms

13F HOLDINGS REPORT, Form 13F Information Table Entry Total, Other Included Managers

3 terms

13F HOLDINGS REPORT financial

"13F HOLDINGS REPORT"

Form 13F Information Table Entry Total financial

"Form 13F Information Table Entry Total"

Other Included Managers financial

"List of Other Included Managers"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was Gilead Sciences' reported 13F value total?

Gilead Sciences reported a Form 13F information-table value total of $1,463,841,605, rounded to the nearest dollar, across 5 entries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 09-30-2026

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	GILEAD SCIENCES, INC.
Address:	333 LAKESIDE DR
	FOSTER CITY, CA 94404
Form 13F File Number:	028-25078
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Andrew D. Dickinson
Title:		Executive Vice President, Chief Financial Officer
Phone:		650-574-3000
Signature, Place, and Date of Signing:
/s/ Andrew D. Dickinson			FOSTER CITY, CA	11-05-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		1
	Form 13F Information Table Entry Total:		5
	Form 13F Information Table Value Total:		1,463,841,605
			(round to nearest dollar)

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]
	No.	Name	Form 13F File No.	CRD No. (if applicable)	SEC File No. (if applicable)	CIK
	1	Gilead Therapeutics A1 Unlimited Co	028-25083			0002055207